The management of retinal vein occlusion: Is interventional ophthalmology the way forward?

British Journal of Ophthalmology

Volumn 90, Issue 5, 2006, Pages 627-639

  Shahid, H ^b   Hossain, P ^c   Amoaku, W M ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b KING EDWARD VII HOSPITAL   (United Kingdom)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; FIBRINOLYTIC AGENT; HEPARIN; STEROID; TISSUE PLASMINOGEN ACTIVATOR; TRIAMCINOLONE;

BLINDNESS; BLOOD CLOT LYSIS; CLINICAL TRIAL; DISEASE CLASSIFICATION; DRUG EFFECT; FIBRINOLYSIS; GLAUCOMA; HEMODILUTION; HUMAN; INTRAOCULAR PRESSURE ABNORMALITY; PATHOGENESIS; PRIORITY JOURNAL; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; REVIEW; SHEATH REMOVAL; STEROID THERAPY; SURGICAL TECHNIQUE; VEIN ANASTOMOSIS; VITRECTOMY; VITREOUS HEMORRHAGE;

ANTICOAGULANTS; COMBINED MODALITY THERAPY; DECOMPRESSION, SURGICAL; GLUCOCORTICOIDS; HUMANS; OPHTHALMOLOGY; RETINAL VEIN; RETINAL VEIN OCCLUSION; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; VITRECTOMY;

EID: 33646259686     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2005.068668     Document Type: Review

References (81)

1. Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 1984;98:271-82.
2. Hayreh SS, Zimmerman MB, Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 1994;117:429-41.
3. Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 1997;115:486-91.
4. Central Vein Occlusion Study Group. Baseline and early natural history report. Arch Ophthalmol 1993;111:1087-95.
5. Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Arch Ophthalmol 1996;114:1243-7.
6. Quinlan PM, Elman MJ, Bhatt AK, et al. The natural course of central retinal vein occlusion. Am J Ophthalmol 1990;110:118-23.
7. Zegarra H, Gutman FA, Conforto J. The natural course of central retinal vein occlusion. Ophthalmology 1979;86:1931-42.
8. Central Vein Occlusion Study Group M Report. Evaluation of grid pattern photocoagulation for macular oedema in central vein occlusion. Ophthalmology 1995;102:1425-33.
9. Branch Vein Occlusion Study Group. Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Arch Ophthalmol 1986;104:34-41.
10. Hayreh SS. Central retinal vein occlusion: differential diagnosis and management. Trans Am Acad Ophthalmol Otolaryngol 1977;83(3 Pt 1):OP379-91.
11. Shaikh S, Blumenkranz MS. Transient improvement in visual acuity and macular edema in central retinal vein occlusion accompanied by inflammatory features after pulse steroid and anti-inflammatory therapy. Retina 2001;21:176-8.
12. Degenring RF, Kamppeter B, Kreissig I, et al. Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion. Acta Ophthalmol Scand 2003;81:548-50.
13. Greenberg PB, Martidis A, Rogers AH, et al. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 2002;86:247-8.
14. Ip M, Kahana A, Altaweel M. Treatment of central retinal vein occlusion with triamcinolone acetonide: an optical coherence tomography study. Sem Ophthalmol 2003;18:67-73.
15. Ip MS, Kumar KS. Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion. Arch Ophthalmol 2002;120:1217-19.
16. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2002;240:782-3.
17. Park CH, Jaffe GJ, Fekrat S. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol 2003;136:419-25.
18. Ip MS, Gottlieb JL, Kahana A, et al. Intravitreal triamcinolone for the treatment of macular oedema associated with central retinal vein occlusion. Arch Ophthalmol 2004;122:1131-6.
19. Bashshur ZF, Ma'luf RN, Allam S, et al. Intravitreal triamcinolone for the management of macular oedema due to nonischaemic central retinal vein occlusion. Arch Ophthalmol 2004;122:1137-40.
20. Antcliff RJ, Spalton DJ, Stanford MR, et al. Intravitreal triamcinolone for uveitic cystoid macular oedema: an optical coherence tomography study. Ophthalmology 2001;108:765-72.
21. Wilson CA, Berkowitz BA, Sato Y, et al. Treatment with intravitreal steroid reduces blood-retina barrier breakdown due to retinal photocoagulation. Arch Ophthalmol 1992;110:1155-9.
22. Nauck M, Karakiulakis G, Perrochoud AP, et al. Corticosteroids inhibit the expression at the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol 1998;341:309-15.
23. Jonas JB, Hayler JK, Sofker A, et al. Regression of neovascular iris vessels by intravitreal injection of crystamne cortisone. J Glaucoma 2001;10:284-7.
24. Chen SD, Lochhead J, Patel CK, et al. Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion. Br J Ophthalmol 2004;88:154-5.
25. Jonas JB, Akkoyun I, Kamppeter B, et al. Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide. Eye, April 2004; Advance e-pub.
26. Kaushik S, Gupta V, Gupta A, et al. Intractable glaucoma following intravitreal triamcinolone in central retinal vein occlusion. Am J Ophthalmol 2004;137:758-60.
27. Duff IF, Falls HF, Linman JW. Anticoagulant therapy in occlusive vascular disease of the retina. Am Arch Ophthalmol 1951;46:601-17.
28. Vannas S, Ritta C. On anticoagulant treatment of occlusion of the central vein of the retina. Acta Ophthalmol 1968;46:730-6.
29. Kohner EM, Pettit JE, Hamilton AM, et al. Streptokinase in central retinal vein occlusion: a controlled clinical trial. BMJ 1976;1:550-3.
30. Elman MJ. Thrombolytic therapy for central retinal vein occlusion: results of a pilot study. Trans Am Ophthal Soc 1996;XCIV:471-504.
31. Lahey JM, Fong DS, Kearney J. Intravitreal tissue plasminogen activator for acute central retinal vein occlusion. Ophthalmic Surg Lasers 1999;30:427-34.
32. Glacet-Bernard A, Kuhn D, Vine AK, et al. Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study. Br J Ophthalmol 2000;84:609-13.
33. Loren U, Frade G, Torrado MC, et al. Thrombus age and tissue plasminogen activator mediated thrombolysis in rats. Thromb Res 1989;56:67-76.
34. Elman MJ, Raden RZ, Carrigan A. Intravitreal injection of tissue plasminogen activator for central retinal vein occlusion. Trans Am Ophthal Soc 2001;99:219-23.
35. Ghazi NG, Noureddine B, Haddad RS, et al. Intravitreal tissue plasminogen activator in the management of central retinal vein occlusion. Retina 2003;23:780-4.
36. Weiss JN. Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein. Am J Ophthalmol 1998;126:142-4.
37. Weiss JN, Bynoe LA. Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology 2001;108:2249-57.
38. Hayreh SS. t-PA in CRVO. Ophthalmology 2002;109:1758-61.
39. Paques M, Vallee JN, Herbreteau D, et al. Superselective ophthalmic artery fibrinolytic therapy for the treatment of central retinal vein occlusion. Br J Ophthalmol 2000;84:1387-91.
40. Vallee JN, Massin P, Aymard A, et al. Superselective ophthalmic arterial fibrinolysis with urokinase for recent severe central retinal venous occlusion: initial experience. Radiology 2000;216:47-53.
41. Vallee JN, Pacques M, Aymard A, et al. Combined central retinal arterial and venous obstruction: emergency ophthalmic arterial fibrinolysis. Radiology 2002;223:351-9.
42. Jorizzo PA, Klein ML, Shults WT, et al. Visual recovery in combined central artery and central vein occlusion. Am J Ophthalmol 1987;104:358-63.
43. Chen HC, Wiek J, Gupta A, et al. Effect of isovolaemic haemodilution on visual outcome in branch retinal vein occlusion. Br J Ophthalmol 1998;82:162-7.
44. Glacet-Bernard A, Zourdani A, Milhoub M, et al. Effect of isovoemic hemodilution in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2001;239:909-14.
45. Hansen LL, Danisevskis P, Arntz H-R, et al. A randomised prospective study on treatment of central retinal vein occlusion by isovolaemic haemodilution and photocoagulation. Br J Ophthalmol 1985;69:108-16.
46. Hansen LL, Wiek J, Wiederholt M, et al. A randomised prospective study of treatment of non-ischaemic central retinal vein occlusion by isovolaemic haemodilution. Br J Ophthalmol 1989;73:895-9.
47. Opremcak EM, Bruce RA, Lomeo MD, et al. Radial optic neurotomy for central retinal vein occlusion: a retrospective pilot study of 11 consecutive cases. Retina 2001;21:408-15.
48. Bynoe LA, Opremcak EM, Bruce RA, et al. Radial optic neurotomy for central retinal vein obstruction. Retina 2002;22:379-80.
49. Hayreh SS, Opremcak EM. Radial optic neurotomy for central retinal vein occlusion. Retina 2002;22:374-7.
50. Weizer JS, Stinnett SS, Fekrat S. Radial optic neurotomy as treatment for central retinal vein occlusion. Am J Ophthalmol 2003;136:814-19.
51. Garciia-Arumii J, Boixadera A, Martinez-Castillo V, et al. Chorioretinal anastomosis after radial optic neurotomy for central retinal vein occlusion. Arch Ophthalmol 2003;121:1385-91.
52. Williamson TH, Poon W, Whitefield N, et al. A pilot study of pars plana vitrectomy, intraocular gas, and radial neurotomy in ischaemic central retinal vein occlusion. Br J Ophthalmol 2003;87:1126-9.
53. Guajardo LL, de la Huerga AM, Sandomingo AF, et al. Radial optic neurotomy as a treatment of central vein occlusion: neurotomy in central vein occlusion. Retina 2003;23:890.
54. Hayreh SS. Radial optic neurotomy for nonischemic central retinal vein occlusion. Arch Ophthalmol 2004;122:1572-3.
55. Vasco-Pasada J. Modification of the circulation in the posterior pole of the eye. Am J Ophthalmol 1972;1:48-59.
56. Arcinegas A. Treatment of the occlusion of the retinal vein by section of the posterior ring. Ann Ophthalmol 1984;16:1081-6.
57. Lee SY, Shin OH, Spoor TO, et al. Bilateral retinal venous calibre decrease following unilateral optic nerve sheath decompression. Ophthalmic Surg 1995;26:25-8.
58. Dev S, Buckley EG. Optic nerve sheath decompression for progressive central retinal vein occlusion. Ophthalmic Surg Lasers 1999;30:181-4.
59. Lit ES, Tsilimbaris M, Gotzaridis E, et al. Lamina puncture: pars plana optic disc surgery for central retinal vein occlusion. Arch Ophthalmol 2002;120:495-9.
60. Verhoeff FH. Successful diathermy treatment in a case of recurring retinal haemorrhages and retinitis proliferans. Arch Ophthalmol 1948;40:239-44.
61. Kwok AKH, Lee VYW, Hon C. Laser induced chorioretinal venous anastomosis in ischaemic central retinal vein occlusion. Br J Ophthalmol 2003;87:1043-55.
62. McAllister IL, Douglas JP, Constable IJ, et al. Laser-induced chorioretinal venous anastomosis for nonischaemic central retinal vein occlusion: evaluation of the complications and their risk factors. Am J Ophthalmol 1998;126:219-29.
63. McAllister IL, Constable IJ. Laser-induced chorioretinal venous anastomosis for treatment of nonischaemic central retinal vein occlusion. Arch Ophthalmol 1995;113:456-62.
64. Fekrat S, Goldberg MF, Finkelstein D. Laser-induced chorioretinal venous anastomosis for nonischaemic central or branch retinal vein occlusion. Arch Ophthalmol 1998;116:43-52.
65. Parodi MB. Laser-induced chorioretinal anastomosis and central retinal vein occlusion. Arch Ophthalmol 1999;117:140-1.
66. Peyman GA, Kishore K, Conway MD. Surgical chorioretinal venous anastomosis for ischaemic central retinal vein occlusion. Ophthalmic Surg Lasers 1999;30:605-14.
67. Avunduk AM, Cetinkaya K, Kapicioglu Z, et al. The effect of posterior vitreous detachment on the prognosis of branch retinal vein occlusion. Acta Ophthalmol Scand 1997;75:441-2.
68. Takahashi MK, Hikichi T, Akiba J, et al. Role of the vitreous and macular oedema in branch retinal vein occlusion. Ophthalmic Surg Lasers 1997;28:294-9.
69. Sebag J, Balazs EA. Pathogenesis of cystoid macular oedema: an anatomic consideration of vitreoretinal adhesions. Surv Ophthalmol 1984;28(suppl):493-8.
70. Stefansson E, Novack RL, Hatchell DL. Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion. Invest Ophthalmol Vis Sci 1990;31:284-9.
71. Yeshaya A, Treister G. Pars plana vitrectomy for vitreous haemorrhage and retinal vein occlusion. Ann Ophthalmol 1983;15:615-17.
72. Amirikia A, Scott IU, Murray TG, et al. Outcomes for vitreoretinal surgery for complications of branch retinal vein occlusion. Ophthalmology 2001;108:372-6.
73. Osterloh MD, Charles S. Surgical decompression of branch retinal vein occlusions. Arch Ophthalmol 1988;106:1469-71.
74. Opremcak EM, Bruce RA. Surgical decompression of branch retinal vein occlusion via arteriovenous crossing sheathotomy: a prospective review of 15 cases. Retina 1999;19:1-5.
75. Mester U, Dillinger P. Vitrectomy with arteriovenous decompression and internal limiting membrane dissection in branch retinal vein occlusion. Retina 2002;22:740-6.
76. Chorbonnel J, Glacet-Bernard A, Korobelnik J, et al. Management of branch retinal vein occlusion with vitrectomy and arteriovenous adventitial sheathotomy, the possible role of surgical posterior vitreous detachment. Graefes Arch Clin Exp Ophthalmol 2004;242:223-8.
77. Shah GK, Sharma S, Fineman MS. Arteriovenous adventitial sheathotomy for the treatment of macular oedema associated with branch retinal vein occlusion. Am J Ophthalmol 2000;129:104-0.
78. Shah GK. Adventitial sheathotomy for treatment of macular oedema associated with branch retinal vein occlusion. Curr Opin Ophthalmol 2000;11:171-4.
79. Cahill MT, Kaiser PK, Sears JE, et al. The effect of arteriovenous sheathotomy on cystoid macular oedema secondary to branch retinal vein occlusion. Br J Ophthalmol 2003;87:1329-32.
80. Le Rouic JF, Bejjani RA, Rumen F, et al. Adventitial sheathotomy for decompression of recent onset branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2001;239:747-51.
81. Garcia-Arumi J, Martinez-Castillo V, Boixadera A, et al. Management of macular oedema in branch retinal vein occlusion with sheathotomy and recombinant tissue plasminogen activator. Retina 2004;24:530-40.